CRIS Current Research Information System

IELASI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.188
NA - Nord America 1.164
EU - Europa 898
AF - Africa 106
SA - Sud America 84
OC - Oceania 2
Totale 4.442
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.143
VN - Vietnam 703
CN - Cina 534
SG - Singapore 531
IT - Italia 297
HK - Hong Kong 147
DE - Germania 135
SE - Svezia 79
KR - Corea 73
GB - Regno Unito 68
IN - India 62
NL - Olanda 58
BR - Brasile 48
FI - Finlandia 48
IE - Irlanda 48
FR - Francia 42
TG - Togo 38
JP - Giappone 30
RU - Federazione Russa 28
AT - Austria 24
ZA - Sudafrica 19
AR - Argentina 18
PH - Filippine 16
ID - Indonesia 15
SC - Seychelles 14
CA - Canada 11
TH - Thailandia 11
BG - Bulgaria 10
PK - Pakistan 9
BD - Bangladesh 8
CI - Costa d'Avorio 8
MX - Messico 8
TR - Turchia 8
NG - Nigeria 7
PL - Polonia 7
UA - Ucraina 7
HR - Croazia 6
IQ - Iraq 6
LT - Lituania 6
MA - Marocco 6
CH - Svizzera 5
EC - Ecuador 5
ES - Italia 5
JO - Giordania 5
MK - Macedonia 5
TW - Taiwan 5
BE - Belgio 4
DZ - Algeria 4
PS - Palestinian Territory 4
VE - Venezuela 4
CL - Cile 3
CZ - Repubblica Ceca 3
EE - Estonia 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
AL - Albania 2
AO - Angola 2
AZ - Azerbaigian 2
HU - Ungheria 2
IR - Iran 2
KZ - Kazakistan 2
LB - Libano 2
MY - Malesia 2
PE - Perù 2
PT - Portogallo 2
PY - Paraguay 2
TN - Tunisia 2
BF - Burkina Faso 1
BH - Bahrain 1
BO - Bolivia 1
CM - Camerun 1
CO - Colombia 1
CY - Cipro 1
EG - Egitto 1
ET - Etiopia 1
JM - Giamaica 1
KE - Kenya 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MN - Mongolia 1
MR - Mauritania 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
RS - Serbia 1
SV - El Salvador 1
TV - Tuvalu 1
Totale 4.442
Salva come PNG Salva come JPEG
Città #
Singapore 375
Ho Chi Minh City 203
Ashburn 198
Hanoi 183
Hefei 157
Hong Kong 130
San Jose 106
Bologna 98
Chandler 78
Santa Clara 72
Fairfield 66
Seoul 62
Southend 50
Beijing 48
Dublin 48
Boardman 39
Helsinki 38
Lomé 38
Da Nang 35
Los Angeles 34
New York 30
Princeton 28
Council Bluffs 27
Dallas 27
Milan 27
Munich 26
Haiphong 25
Tokyo 24
Lauterbourg 23
Frankfurt am Main 22
Dong Ket 21
Houston 21
Rome 21
Wilmington 21
Woodbridge 19
Vienna 18
Amsterdam 15
Bengaluru 14
Redondo Beach 14
Seattle 14
Guangzhou 13
Johannesburg 13
Ann Arbor 12
Cambridge 11
Hải Dương 11
Falkenstein 10
Jakarta 10
Nuremberg 10
Orem 10
Sofia 10
Des Moines 9
Falls Church 9
San Giovanni in Persiceto 9
Thái Nguyên 9
Abidjan 8
Berlin 8
Can Tho 8
Shanghai 8
Shenzhen 8
Buffalo 7
Chicago 7
Nanjing 7
Abeokuta 6
Lahore 6
London 6
Ninh Bình 6
Shenyang 6
Washington 6
Amman 5
Bern 5
Biên Hòa 5
Brooklyn 5
Ha Long 5
Lappeenranta 5
Skopje 5
São Paulo 5
Tongling 5
Toronto 5
Turin 5
Turku 5
Warsaw 5
Westminster 5
Bremen 4
Brussels 4
Bắc Giang 4
Bắc Ninh 4
Bến Tre 4
Chennai 4
Florence 4
Genoa 4
Hangzhou 4
Long Xuyen 4
Manila 4
Mountain View 4
Nha Trang 4
Phoenix 4
Phú Thọ 4
Qingdao 4
Redwood City 4
Rio de Janeiro 4
Totale 2.880
Salva come PNG Salva come JPEG
Nome #
Beneficial prognostic effects of aspirin in patients receiving sorafenib for hepatocellular carcinoma: A tale of multiple confounders 250
Prognostic Impact of Metastatic Site in Patients Receiving First-Line Sorafenib Therapy for Advanced Hepatocellular Carcinoma 222
Direct oral anticoagulants for the treatment of splanchnic vein thrombosis: A state of art 201
Intermediate-stage hepatocellular carcinoma: refining substaging or shifting paradigm? 194
Comparison of Prognostic Scores in Patients With Hepatocellular Carcinoma Treated With Sorafenib 175
Suboptimal outcomes of sorafenib as a second-line treatment after atezolizumab-bevacizumab for unresectable hepatocellular carcinoma 171
Repeated Previous Transarterial Treatments Negatively Affect Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib 169
Donafenib in hepatocellular carcinoma 169
Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients 161
TKIs in combination with immunotherapy for hepatocellular carcinoma 155
Natural history of hypovascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced mr imaging in cirrhotic patients during surveillance program 154
Treatment of combined hepatocellular and cholangiocarcinoma 154
Outcomes of Sorafenib for Recurrent Hepatocellular Carcinoma After Liver Transplantation in the Era of Combined and Sequential Treatments 150
An update of treatments of hepatocellular carcinoma in patients refractory to sorafenib 150
Correction to: Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma (Targeted Oncology, (2020), 15, 6, (773-785), 10.1007/s11523-020-00757-3) 147
Experience with regorafenib in the treatment of hepatocellular carcinoma 147
Association of NOS3 and ANGPT2 Gene Polymorphisms with Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib: Results of the Multicenter Prospective INNOVATE Study 143
Outcome of hepatic resection for HCC in ideal and non-ideal candidates 134
Current guidelines for diagnosis and management of hepatic involvement in hereditary hemorrhagic teleangiectasia 134
Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma 123
A case of Leishmania infection with focal splanchnic involvement without systemic symptoms: a potential anti-inflammatory role for vitamin D 122
Long-lasting remission in a metastatic hepatocellular carcinoma patient after combined regorafenib therapy and surgery 120
Lenvatinib mesylate to treat hepatocellular carcinoma 117
Hot topics in hepatocellular carcinoma 116
Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with regorafenib 115
Comparative Analysis of Subclassification Systems in Patients with Intermediate-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Classification B) Receiving Systemic Therapy 111
Identification of Regorafenib Prognostic Index (REP Index) via Recursive Partitioning Analysis in Patients with Advanced Hepatocellular Carcinoma Receiving Systemic Treatment: A Real-World Multi-Institutional Experience 101
A Case of Advanced Hepatocellular Carcinoma with Bone Metastases Managed with Tyrosine Kinase Inhibitors and Aggressive Palliative Radiation Therapy: Role of Combination Therapy for Extending Survival 95
An update on atezolizumab for hepatocellular carcinoma 91
Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis 86
Absence of Viral Replication Is Associated With Improved Outcome in Anti-HCV-Positive Patients With Hepatocellular Carcinoma 70
Recurrence rate, features, and outcome after hepatocellular carcinoma curative resection or ablation according to the IMbrave050 criteria: a real-world study 49
Tumour Burden Score as a Predictor of Extrahepatic Progression After Transarterial Chemoembolization for Hepatocellular Carcinoma: An Observational Multicenter Study 43
Anabolic Androgenic Steroids and Hepatocellular Adenoma and Carcinoma: Molecular Mechanisms and Clinical Implications 14
Totale 4.553
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.956
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.956
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202151 0 0 0 0 0 0 0 0 0 7 7 37
2021/2022314 10 1 19 8 29 18 8 35 22 13 105 46
2022/2023358 26 54 13 39 40 27 32 19 61 5 9 33
2023/2024210 7 26 14 14 39 43 10 13 14 10 12 8
2024/2025948 36 65 73 75 106 34 111 37 29 64 76 242
2025/20262.463 242 219 169 159 195 75 541 126 563 174 0 0
Totale 4.553